SHOULDER INNOVATIONS, INC. SI
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-31
SHOULDER INNOVATIONS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 76.5% | 77.0% |
| Operating margin | -55.6% | -46.3% |
| Net margin | -85.3% | -49.4% |
| FCF margin | -76.1% | -57.4% |
| Return on assets | -23.8% | -36.3% |
| Return on equity | -28.7% | 28.6% |
| Debt / equity | 0.11× | -0.27× |
| Current ratio | 11.07 | 4.59 |
| Revenue growth | 49.6% | — |
Source: SEC EDGAR filings · CIK 0001699350 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.